Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexgel (NXGL) Return on Sales (2018 - 2025)

Historic Return on Sales for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to 0.22%.

  • Nexgel's Return on Sales rose 400.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year increase of 3300.0%. This contributed to the annual value of 0.4% for FY2024, which is 3800.0% up from last year.
  • Nexgel's Return on Sales amounted to 0.22% in Q3 2025, which was up 400.0% from 0.22% recorded in Q2 2025.
  • Nexgel's 5-year Return on Sales high stood at 0.22% for Q3 2025, and its period low was 4.64% during Q1 2022.
  • Its 5-year average for Return on Sales is 1.33%, with a median of 1.02% in 2022.
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 50300bps in 2021, then crashed by -20000bps in 2022.
  • Quarter analysis of 5 years shows Nexgel's Return on Sales stood at 1.66% in 2021, then soared by 39bps to 1.02% in 2022, then dropped by -7bps to 1.1% in 2023, then skyrocketed by 75bps to 0.27% in 2024, then increased by 19bps to 0.22% in 2025.
  • Its Return on Sales was 0.22% in Q3 2025, compared to 0.22% in Q2 2025 and 0.24% in Q1 2025.